(Page 13 of 24)
|NEXT IMAGE >>|
|Reinventing Biotech’s Business Model— Cliff Stocks, the CEO of Theraclone Sciences (left) talked about incorporating some of the business lessons learned from two very different models at his past companies, Icos and Calistoga Pharmaceuticals. On the right is Alex Lash of Startup magazine, who moderated the second half of afternoon chats.|
|Photo by Luke Timmerman|
By posting a comment, you agree to our terms and conditions.